PAREXEL, Eli Lilly to develop China’s Clinical Research workforce

Clinical Research |  News | 0 Comment | 06 Dec, 2018

PAREXEL, a leading innovator of global biopharmaceutical services, has announced a new collaboration with Eli Lilly and Company to launch a clinical research learning and development progra...Read more

argenx collaborates with Cilag GmbH International

Clinical Research |  News | 0 Comment | 03 Dec, 2018

argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement for with Cilag GmbH International, an affiliate of the Janssen Pharmace...Read more

ViaCyte Secures $80 Million Financing for Insulin-Requiring Diabetes

Clinical Research |  News | 0 Comment | 30 Nov, 2018

Clinical stage regenerative medicine company has announced an $80 million Series D financing led by Bain Capital Life Sciences and joined by TPG and RA Capital Management, as well as existi...Read more

Tessa appoints Dr. Ivan Horak as president of R&D

Clinical Research |  News | 0 Comment | 29 Nov, 2018

Singapore –Tessa Therapeutics, a clinical stage biopharmaceutical company focusing on cellular immunotherapy treatments for cancer, announced the appointment of Ivan D. Horak as ...Read more

DRC initiates first-ever multi-drug Ebola trial

Clinical Research |  News | 0 Comment | 27 Nov, 2018

First-ever multi drug trial for an Ebola treatment has been announced by The Ministry of Health of the Democratic Republic of the Congo (DRC). This randomized control trial has begun to eva...Read more

First asian real-world experience of regorafenib presented at ESMO Asia

Clinical Research |  News | 0 Comment | 26 Nov, 2018

Singapore – A new multicenter, retrospective analysis of South Korean patients highlighted that the oral targeted therapy regorafenib is effective and well-tolerated for second-line t...Read more

Merck, Pfizer give information of Avelumab in Refractory Ovarian Cancer

Clinical Research |  News | 0 Comment | 20 Nov, 2018

Merck and Pfizer Inc. announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy,...Read more

Vyera to Initiate Phase 1 Study of NCE for Toxoplasmosis

Clinical Research |  News | 0 Comment | 16 Nov, 2018

Vyera Pharmaceuticals, LLC  has announced that it plans to initiate a Phase 1 single ascending dose (SAD) study of VYR-006, a novel dihydrofolate reductase (DHFR) inhibitor which Vyera...Read more

Nashville Biosciences enters into agreement with BC Platforms

Clinical Research |  News | 0 Comment | 15 Nov, 2018

Singapore - BC Platforms, a world leader in secure genomic data management and analytics, announces an agreement with Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt Uni...Read more

3-D study delivers first pre-clinical results on the toxicological impact of novel e-cigarette

Clinical Research |  News | By Keyur Trivedi, M.Phil., M.Sc., Philip Morris International | 0 Comment | 12 Nov, 2018

Singapore - Philip Morris International (PMI), has conducted an in vitro study using epithelial cells taken from the mouth and small airways of a human donor, in early stage, pre-clinical a...Read more

Adagene announces acceptance of IND in China for ADG-106

Clinical Research |  News | 0 Comment | 01 Nov, 2018

Adagene, an innovative antibody engineering and discovery company based in Suzhou, China as well as San Francisco, California has announced the dosing of its first patient in its Phase I tr...Read more

Daiichi enters clinical collaboration with Merck, Pfizer

Clinical Research |  News | 0 Comment | 27 Oct, 2018

Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck KGaA, Darmstadt, Germany and Pfizer, Inc. to evaluate the combination ...Read more

Eisai announces Data from the Phase II Clinical Trial of BAN2401

Clinical Research |  News | 0 Comment | 26 Oct, 2018

Eisai Co., Ltd. and Biogen Inc. announced that Eisai presented the latest data from the Phase II clinical study (Study 201) of BAN2401, an anti-amyloid beta protofibril antibody, in 856 pat...Read more

Reistone Biopharma to intiate Ph 2 clinical trial of Ulcerative Colitis globally

Clinical Research |  News | 0 Comment | 23 Oct, 2018

Reistone Biopharma Company Limited, a clinical stage biopharmaceutical company headquartered in Shanghai has announced the US FDA approval of IND for phase II clinical trial to invest...Read more

ASLAN reveals promising data for advanced solid tumour drug

Clinical Research |  News | 0 Comment | 22 Oct, 2018

Singapore – ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States...Read more

apceth Biopharma announces positive results for apceth-201 in mouse models

Clinical Research |  News | 0 Comment | 19 Oct, 2018

apceth Biopharma GmbH, a company with the mission of improving patients’ lives with next generation cell therapies has announced positive results for apceth-201 in mouse models for ac...Read more

Medivir lowers research costs to focus on clinical development

Clinical Research |  News | 0 Comment | 17 Oct, 2018

Singapore - Medivir AB announced plans to reduce activities not critical to its development pipeline of drug candidates as part of its enhanced focus on clinical stage projects. As part of...Read more

Alphamab starts phase I clinical trial in Australia

Clinical Research |  News | 0 Comment | 11 Oct, 2018

Alphamab Oncology has announced that its proprietary humanized PD-L1 - CTLA-4 bispecific antibody program, the first of its class, has recently started phase I clinical trial in Australia. ...Read more